RBC Life Sciences Reports Second Quarter Results.IRVING, Texas -- RBC RBC red blood cell. RBC or rbc abbr. red blood cell RBC, n See red blood cell count. RBC red blood cells; red blood (cell) count (see blood count). Life Sciences, Inc. (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :RBCL RBCL Road and Bridge Contract Limits ) today reported a 16% increase in net sales to $6,203,000 in the second quarter of 2006 compared to net sales of $5,358,000 in the same period of last year. Earnings before income taxes for the second quarter of 2006 increased 19% to $453,000. The Company's net earnings in the second quarter of 2006 were $293,000, or $0.01 per share, compared to net earnings of $380,000, or $0.02 per share, in the second quarter of 2005. Clinton Howard, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. said, "The increase in second quarter earnings before income taxes over the same period last year was achieved even though this year we expensed general and administrative costs of approximately $309,000 related to our new subsidiary in South Korea. This earnings growth was driven by improved operating margins and sales increases in both of our operating segments, with particularly strong sales growth in nutritional product sales to our overseas licensees. Because earnings have now offset our net operating loss carryforwards Net operating loss carryforwards Application of losses to offset earnings in future years. , as determined for financial reporting purposes, we recorded a tax provision of $160,000 in the second quarter of 2006, which reduced net earnings below net earnings reported for the second quarter of 2005." On June 8, 2006 the Company name was changed from Royal BodyCare, Inc. to RBC Life Sciences, Inc. as approved by stockholders. RBC Life Sciences, a fully reporting company, was assigned a new OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. trading symbol, RBCL. The Company manufactures dietary supplements, including buffered magnesium ascorbate a·scor·bate n. A salt of ascorbic acid. ascorbate a compound or derivative of ascorbic acid. See also sodium ascorbate. , and the antioxidant antioxidant, substance that prevents or slows the breakdown of another substance by oxygen. Synthetic and natural antioxidants are used to slow the deterioration of gasoline and rubber, and such antioxidants as vitamin C (ascorbic acid), butylated hydroxytoluene , Microhydrin(R) Plus (TM) which scavenges free radicals that attack vital tissues. It also increases cellular hydration hydration /hy·dra·tion/ (hi-dra´shun) the absorption of or combination with water. hy·dra·tion n. 1. The addition of water to a chemical molecule without hydrolysis. 2. , recharges other antioxidants Antioxidants Substances that reduce the damage of the highly reactive free radicals that are the byproducts of the cells. Mentioned in: Aging, Nutritional Supplements antioxidants, n. , and reduces lactic acid during strenuous labor or exercise. The Company markets other supplements often missing in modern diets, through independent distributors in North America, South Korea, and through international licensees. MPM MPM Multi-Processing Module (Apache) MPM Manufacturing Process Management MPM Milwaukee Public Museum MPM MMW (Millimeter Wave) Power Module MPM Master of Project Management (degree) Medical, a wholly owned subsidiary Wholly Owned Subsidiary A subsidiary whose parent company owns 100% of its common stock. Notes: In other words, the parent company owns the company outright and there are no minority owners. of RBC, develops and markets a proprietary line of prescription and nonprescription non·pre·scrip·tion adj. Sold legally without a physician's prescription; over-the-counter. products for wound management, sold through medical-surgical dealers, to nursing homes, hospitals, and cancer clinics. The statements above, other than statements of historical facts, may be forward-looking. Actual events will be dependent upon a number of factors and risks including but not limited to changes in plans by the Company's management, delays or problems in production, changes in the regulatory process, changes in market trends, and a number of other factors and risks described from time to time in the Company's filings with the Securities and Exchange Commission.
RBC Life Sciences, Inc.
Summary Results of Operations
Quarters Ended June 30,
-------------------------
2006 2005
------------ ------------
Net sales $6,203,000 $5,358,000
Earnings before income taxes $453,000 $380,000
Provision for income taxes 160,000 --
------------ ------------
Net earnings $293,000 $380,000
============ ============
Earnings per share -- basic and diluted $0.01 $0.02
============ ============
Weighted average shares outstanding -- basic 20,155,294 20,056,294
============ ============
Weighted average shares outstanding --
diluted 22,404,118 21,183,028
============ ============
Six Months Ended June 30,
-------------------------
2006 2005
------------ -----------
Net sales $11,011,000 $9,498,000
Earnings before income taxes $414,000 $372,000
Provision for income taxes 160,000 --
------------ -----------
Net earnings $254,000 $372,000
============ ===========
Earnings per share -- basic and diluted $0.01 $0.02
============ ===========
Weighted average shares outstanding -- basic 20,149,794 20,056,294
============ ===========
Weighted average shares outstanding --
diluted 22,491,663 20,619,661
============ ===========
|
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion